Eugenia Shmidt – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emaileshmidtumnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Finished
7 Active

7 results

Filter

Active
Proactive optimization of infliximab using a pharmacokinetic dashboard versus standard of care inpatients with Crohn???s disease: The OPTIMIZE Trial
Shmidt, E. & Vaughn, B. P.
BETH ISRAEL DEACONESS MEDICAL CENTER, LEONA M & HARRY B HELMSLEY CHAR. TRUST
3/1/21 → 2/29/24
Project: Research project
Prospective Blood Sample Collection Study for Product Development in Detecting Colorectal Cancer and Advanced Adenomas
Shmidt, E., Madoff, R. D. & Shaukat, A.
FREENOME HOLDINGS, INC
10/2/20 → 12/31/23
Project: Research project
A MULTICENTER, LONGITUDINAL, PROSPECTIVE, PHARMACOKINETIC,PHASE 1B STUDY IN WOMEN WITH CHRONIC INFLAMMATORY DISEASES TREATED WITHCIMZIA® (CERTOLIZUMAB PEGOL) DURING PREGNANCY
Shmidt, E.
UCB PHARMA S.A.
2/26/20 → 2/28/24
Project: Research project
An Open-Label, Phase 4 Study to Evaluate the Efficacy and Safety of Triple Combination Therapy With Vedolizumab IV, Adalimumab SC, and Oral Methotrexate in Early Treatment of Subjects With Crohn's Disease Stratified at Higher Risk for Developing Complica
Shmidt, E.
TAKEDA DEVELOPMENT CENTER AMERICAS, INC.
5/1/19 → 5/31/24
Project: Research project
RPC01-3202: Induction Study #2 - A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Shmidt, E. & Vaughn, B. P.
CELGENE CORPORATION
2/1/18 → 12/31/24
Project: Research project
RPC01-3203: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Shmidt, E.
CELGENE CORPORATION
2/1/18 → 12/31/24
Project: Research project
RPC01-3204: A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn,s Disease
Shmidt, E.
CELGENE CORPORATION
2/1/18 → 12/31/24
Project: Research project